Navigation Links
Restoration Of Fertility After Cancer Treatment

For women who suffer from infertility caused by cancer treatments, help may be right around the corner . A new study shows // a technique may help these women gain back their fertility -- even after going into menopause .Cancer treatments such as chemotherapy, radiation and radical surgery can cause a woman to experience premature menopause and diminish her chance of getting pregnant.

Researchers in New York froze a 30-year-old woman’s ovarian tissue to determine if they could preserve her fertility. The woman suffered from breast cancer before experiencing chemotherapy-induced menopause. Researchers transplanted the tissue beneath the woman’s abdomen six years after she underwent cancer treatment. The woman’s ovaries began to function again three months after the procedure. The woman also underwent in-vitro fertilization, which resulted in the development of a four-cell embryo. The embryo was implanted, but she did not become pregnant.

However researchers say their results are promising and they say that this research represents a potentially significant reproductive advancement in two respects: First, women can preserve their fertility by freezing their ovarian tissue, and second, pregnancy may be possible even after the tissue remains frozen for a long time.

However researchers warn that freezing ovarian tissue may pose risks and in light of the current uncertainty about the effectiveness and safety of ovarian cryostorage and grafting, the whole procedure should still be presented as experimental to patients.
'"/>




Page: 1

Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Mobile Phones Found To Reduce A Man’s Fertility by 30
3. High-Protein Diet Found To Reduce Fertility
4. Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems
5. Improving Fertility In Patients With Cervical Cancer
6. Late Pregnancy Women Face The Risk Of Heartbreak, Fertility Problems
7. Fertility Treatment Offered During Summer Has Better Chances For Success
8. Detrimental Effect Of Chronic Alcoholism On Male Fertility
9. Fertility increased in Thirties
10. New Home-Fertility Kit Launched For Men
11. Ramadoss to Take Severe Action against Fertility Clinics Conducting Stem Cell Therapy
Post Your Comments:
(Date:5/16/2008)...EWPORT BEACH, Calif., May 16 /PRNewswire-FirstCall...P ) announced today the promotion of David,M. Boit... Officer. "Dave,has made a tremendous contribution...y our strong investment growth and diversification... over $1 billion in accretive,investments for NHP,...
(Date:5/16/2008)...AN DIEGO, May 16 /PRNewswire-FirstCall/ -- CryoCor...cused on the treatment of cardiac,arrhythmias, ann...ers of,CryoCor common stock filed a complaint in t...ty of San Diego, naming as defendants each member ...Boston Scientific Corporation.,The complaint is st...
(Date:5/16/2008)...ment guidelines quickly disseminated to community ...16 (HealthDay News) -- Partnerships between major ...e a quick and effective way to spread cancer treat... Center in Philadelphia. , Most new cancer trea...ost cancer care is provided at community hospitals...
(Date:5/16/2008)...ismatch in some early stage cases makes therapy of...RIDAY, May 16 (HealthDay News) -- Colon cancer pat...need to receive chemotherapy. In fact, not only do..., it may actually harm them, a new study found. ,...ncer], then you should not be treated with chemoth...
Breaking Medicine News(10 mins):Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2
...ai: The incidence of cancer and death from cancer ...to sources with the Shanghai// Disease Prevention ...ancer patients in the Shanghai urban area has almo...d more younger women are contracting the disease, ...
...survey confirms that pulmonary/critical care physi... and are actively managing// their patients’ sleep...f Chest Physicians Sleep Institute (ACCP-SI). It w...ians are well informed about the sleep patterns of...
...are varied reactions to the U.S panel hearing tha...factured. The Senate Health, Education, Labor an...at would give the Food and Drug Administration leg...ve versions of expensive biologic drugs after pate...
...lhi: The National Commission for Women has stresse...n the light of the increasing number of mentally i...e grappling with mental illness. "Mental health ... think India needs to review its archaic law and b...
Other Medicine News:Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3Health News:Generic Biologics – U.S Panel Hearing Draws Mixed Response 2Health News:Five Million Indian Women Suffer Mental Illness 2
(Date:5/15/2008)...search reflects depth and breadth of, collaborati...atments for diverse forms o...f Zometa(R), the leading IV, bisphosphonate, on re...cer, - Four oral sessions to feature RAD001, firs...ncluding first results of RECORD-1 study in renal ...
(Date:5/15/2008)... France, May 15 /- Cerenis,Therapeuti...ompany,developing HDL-related compounds for the tr...today announced that it has completed a Phase I,cl...d product candidates.,CER-002 is a peroxisome prol...agonist in development for the treatment of cardio...
(Date:5/15/2008)...or an Antiplatelet Therapy that, Combined, with As...f Plavix/Iscover and Aspirin, According to a N..., May 15 /- Decision Resources, one o...for pharmaceutical and,healthcare issues, finds th...vement in patient compared to Sanofi-Aventis/Brist...
(Date:5/15/2008)...swire/ -- Omega 3 fatty acids bound to,phospholipi... natural,alternative and may have beneficial effec...French study reveals. While several studies have r...vity, French researchers have,hypothesized that Ve...,impulse control., These research findings have l...
Breaking Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3A step toward tissue engineered heart structures for children 355 1A step toward tissue engineered heart structures for children 355 2Microbiotic technology developed for microinjection of zebrafish embryos 1069 1Mathematics might save you a trip to the ER 1066 1Mathematics might save you a trip to the ER 1066 2Thousands of starving children could be restored to health with peanut butter program 353 1Thousands of starving children could be restored to health with peanut butter program 353 2Thousands of starving children could be restored to health with peanut butter program 353 3
...tients Achieved at Least 75 Percent Improvement in...of Five Dosing Groups, More,Than Half Achieved 90 ...07 /PRNewswire-FirstCall/ -- New,Phase II study re...-874, reduced psoriasis symptoms significantly in ...e out of 10 patients with,moderate to severe psori...
...-(BUSINESS WIRE)--May 3, 2007 - New data show the,...ction of chorea,associated with Huntington,s disea...ssfully completed treatment in a 13-week trial.,Th...ccessfully to,sustain reduced chorea burden in lon...tial benefit of,tetrabenazine as maintenance thera...
Other Medicine Technology:Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4Clinical Trial Results Suggest Long-Term Treatment Benefit of,Tetrabenazine for Chorea Associated with Huntington's Disease 2Clinical Trial Results Suggest Long-Term Treatment Benefit of,Tetrabenazine for Chorea Associated with Huntington's Disease 3
Self retaining brain retractor.
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required.
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm).
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm).
Medicine Products: